The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2-specific data are lacking

Agency's approach for assessing risks to endangered species relies on real-world data

Ammonium salts may serve as nitrogen reservoirs on the icy bodies, suggesting a common origin for comets and the sun

The US has a fraught history at the intersection of science and China relations

Strategy reduces volumes and times needed to evaluate CO₂-switchable systems

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19

An unconventional design doubles the storage capacity of a low-cost, and nontoxic battery for the renewable grid

Many are FDA-approved drugs that could be repurposed

Italian workers threaten to strike, but German, UK companies and workers pull together

Long-awaited image of elusive disordered tail helps scientists better understand the enzyme's mechanism

Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far

The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for COVID-19

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts

Technology could lessen the environmental impact of 3-D printed buildings by adapting locally harvested soils

Lingering logistic problems and a sputtering economy mean hard times for companies

With a diagnostic backlog hampering disease control efforts, scientists are turning to CRISPR and other technologies to bridge the gap

Drugmakers want to keep trials going but acknowledge that medical resources are strained

Lingering logistic problems and a sputtering economy mean hard times for companies

Editors in Europe and the US plan to work with authors whose lives and labs have been disrupted by the novel coronavirus

Fingers are being pointed in the Netherlands and the UK over reagent capacity constraints

Open-access collection contains nearly 50,000 chemical compounds from the CAS Registry

Technology could reduce the environmental impact of 3-D printed buildings by adapting locally harvested soils

Inspector general finds agency hasn't reached out to those living near 9 chemical plants

Stable organic radical replaces alkali metals or dissolving metal reductants in certain reactions

Inspired by spider legs, researchers make nanoscopic structures that don't get caught up in structural stickiness

The chemist wants the Gates Foundation–backed institute to share its expertise during the coronavirus pandemic and advocate for public health

Inspector general finds agency hasn't reached out to those living near 9 chemical plants

Regulators are restricting reusable bags over worries they might harbor virus

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease

Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus's spread

Mauro Ferrari quits after three months at the helm

Structural data on the complex could guide drug and vaccine design

Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus's spread

Regulators are restricting reusable bags over worries they might harbor virus

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease

Phi and delta orbital interactions could improve nuclear waste management

Gilead's Chief Medical Officer talks about the challenges of clinical design in the time of COVID-19

Variáveis em tecidos, ajuste e comportamento do usuário podem influenciar a eficácia com que uma máscara pode bloquear a propagação do vírus